Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating luteal phase support with a GnRH agonist after GnRH agonist triggering in IVF/ICSI cycles; currently recruiting in Paris, Fran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection | Phase 3 | Status: RECRUITING